Benitec Biopharma (BNTC) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2025 value amounting to -$0.21.
- Benitec Biopharma's EPS (Weighted Average and Diluted) fell 9090.91% to -$0.21 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.03, marking a year-over-year increase of 8291.87%. This contributed to the annual value of -$1.05 for FY2025, which is 1393.44% up from last year.
- Benitec Biopharma's EPS (Weighted Average and Diluted) amounted to -$0.21 in Q2 2025, which was down 9090.91% from -$0.38 recorded in Q1 2025.
- Benitec Biopharma's 5-year EPS (Weighted Average and Diluted) high stood at -$0.11 for Q2 2024, and its period low was -$9.88 during Q2 2022.
- Over the past 5 years, Benitec Biopharma's median EPS (Weighted Average and Diluted) value was -$0.62 (recorded in 2021), while the average stood at -$2.12.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 118709.68% in 2022, then skyrocketed by 9584.91% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's EPS (Weighted Average and Diluted) stood at -$0.59 in 2021, then crashed by 466.1% to -$3.34 in 2022, then rose by 20.96% to -$2.64 in 2023, then soared by 90.15% to -$0.26 in 2024, then increased by 19.23% to -$0.21 in 2025.
- Its last three reported values are -$0.21 in Q2 2025, -$0.38 for Q1 2025, and -$0.26 during Q4 2024.